Biotech Values

[Titan V]

Competition is healthy. However, just some high level observation: Echosens partnered with GE in April 2017. GE and Endra renewed and extended their partnership in February 2018. Perhaps GE felt more to be desired from a device in this area than what it was getting from Echosens.

ENDRA Life Sciences Renews and Extends Term of Collaboration Agreement with GE Healthcare to Develop ENDRA's TAEUS(TM) Clinical Product Targeting Non-Alcoholic Fatty Liver Disease
http://investors.endrainc.com/prviewer/release_only/id/2926860

Under the terms of the agreement, GE Healthcare will continue to support ENDRA's efforts to complete commercialization of its TAEUS technology for use in a fatty liver application by, among other things, providing equipment and technical advice, and facilitating introductions to GE Healthcare clinical ultrasound customers. In return for this assistance, ENDRA will afford GE Healthcare certain rights of first offer with respect to manufacturing and licensing rights for the target application.